{"data":[{"accessionNo":"0001950047-26-009497","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"THEODORE HUIZENGA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1283,"aggregateMarketValue":17461.63,"unitsOutstanding":98588873,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15"},{"accessionNo":"0001950047-26-007510","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4696,"aggregateMarketValue":117024.32,"unitsOutstanding":98489224,"approxSaleDate":"2026-08-03","exchange":"NASDAQ","filedAt":"2026-08-03"},{"accessionNo":"0001950047-26-006703","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4698,"aggregateMarketValue":155644.74,"unitsOutstanding":98489224,"approxSaleDate":"2026-07-01","exchange":"NASDAQ","filedAt":"2026-07-01"},{"accessionNo":"0001950047-26-006073","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"CORAZON D. SANDERS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2000,"aggregateMarketValue":50100,"unitsOutstanding":98489224,"approxSaleDate":"2026-06-15","exchange":"NASDAQ","filedAt":"2026-06-15"},{"accessionNo":"0001950047-26-006115","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"KARAH PARSCHAUER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3799,"aggregateMarketValue":92505.65,"unitsOutstanding":98489000,"approxSaleDate":"2026-06-15","exchange":"NASDAQ","filedAt":"2026-06-15"},{"accessionNo":"0001950047-26-005347","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4653,"aggregateMarketValue":110601.81,"unitsOutstanding":98489224,"approxSaleDate":"2026-06-01","exchange":"NASDAQ","filedAt":"2026-06-01"},{"accessionNo":"0001950047-26-004713","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"SHEHNAAZ SULIMAN","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5740,"aggregateMarketValue":144188.8,"unitsOutstanding":98489224,"approxSaleDate":"2026-05-18","exchange":"NASDAQ","filedAt":"2026-05-18"},{"accessionNo":"0001950047-26-003887","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4683,"aggregateMarketValue":116606.7,"unitsOutstanding":96629788,"approxSaleDate":"2026-05-01","exchange":"NASDAQ","filedAt":"2026-05-01"},{"accessionNo":"0001950047-26-003127","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4683,"aggregateMarketValue":98202.51,"unitsOutstanding":96629788,"approxSaleDate":"2026-04-01","exchange":"NASDAQ","filedAt":"2026-04-01"},{"accessionNo":"0001950047-26-002450","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"KARAH PARSCHAUER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3508,"aggregateMarketValue":79526.36,"unitsOutstanding":96629788,"approxSaleDate":"2026-03-10","exchange":"NASDAQ","filedAt":"2026-03-10"},{"accessionNo":"0001950047-26-002334","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"KARAH PARSCHAUER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6018,"aggregateMarketValue":128774.97,"unitsOutstanding":96629788,"approxSaleDate":"2026-03-06","exchange":"NASDAQ","filedAt":"2026-03-06"},{"accessionNo":"0001950047-26-002108","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1635,"aggregateMarketValue":36624,"unitsOutstanding":96629788,"approxSaleDate":"2026-03-03","exchange":"NASDAQ","filedAt":"2026-03-03"},{"accessionNo":"0001950047-26-002038","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3119,"aggregateMarketValue":70302.26,"unitsOutstanding":96629788,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001950047-26-000800","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3061,"aggregateMarketValue":72117.16,"unitsOutstanding":96477569,"approxSaleDate":"2026-02-02","exchange":"NASDAQ","filedAt":"2026-02-02"},{"accessionNo":"0001950047-26-000020","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3150,"aggregateMarketValue":71946,"unitsOutstanding":96477569,"approxSaleDate":"2026-01-02","exchange":"NASDAQ","filedAt":"2026-01-02"},{"accessionNo":"0001950047-25-010053","issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC.","ticker":"RARE","personName":"HOWARD HORN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3081,"aggregateMarketValue":112086.78,"unitsOutstanding":96477569,"approxSaleDate":"2025-12-10","exchange":"NASDAQ","filedAt":"2025-12-10"}],"updatedAt":"2026-10-13T07:34:33.261Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}